QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-outperform-on-meiragtx-hldgs-maintains-11-price-target

RBC Capital analyst Luca Issi reiterates MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and maintains $11 price target.

 recap-meiragtx-hldgs-q4-earnings
Recap: MeiraGTx Hldgs Q4 Earnings
03/14/2024 21:50:07

Core News & Articles

MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the achievem...

 why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

 why-is-eye-disease-related-gene-therapy-focused-meiragtx-stock-soaring-today

MeiraGTx Holdings plc (NASDAQ: MGTX) on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a John...

 meiragtx-hldgs-q3-eps-074-misses-055-estimate-sales-510m-beat-327m-estimate

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0....

 why-on-semiconductor-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire...

 why-is-gene-therapy-company-meiragtx-stock-trading-higher-today

MeiraGTx Holdings plc (NASDAQ: MGTX) shares are trading higher after French pharma giant Sanofi SA (NASDAQ: SNY) made a $30 mil...

 meiragtx-announces-an-oral-presentation-and-eight-posters-at-the-european-society-of-gene-and-cell-therapy-2023-annual-congress

MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company ...

 rbc-capital-maintains-outperform-on-meiragtx-hldgs-lowers-price-target-to-11

RBC Capital analyst Luca Issi maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and lowers the price target from $13 ...

 chardan-capital-reiterates-buy-on-meiragtx-hldgs-maintains-41-price-target

Chardan Capital analyst Geulah Livshits reiterates MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and maintains $41 price target.

 meiragtx-hldgs-q2-eps-053-up-from-076-yoy-sales-354m-down-from-1076m-yoy

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.53) per share. This is a 30.26 percent increase over losses of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION